OTCMKTS:BABYF Else Nutrn (BABYF) Stock Price, News & Analysis $0.03 0.00 (-12.43%) As of 05/15/2026 03:50 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About Else Nutrn Stock (OTCMKTS:BABYF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Else Nutrn alerts:Sign Up Key Stats Today's Range$0.02▼$0.0450-Day Range$0.02▼$0.0952-Week Range$0.02▼$0.80Volume554,139 shsAverage Volume140,858 shsMarket Capitalization$1.55 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Else Nutrition Holdings Inc is a plant-based infant and toddler nutrition company that develops dairy-free, soy-free and gluten-free formula powders under its flagship ELSE brand. The company’s core product line includes Stage 1 infant formula and Stage 3 toddler nutrition powders formulated with a proprietary blend of almond, buckwheat and tapioca ingredients designed to mimic the nutritional profile of traditional milk‐based formulas. These products are non-GMO and aim to address food sensitivities and allergen concerns in early childhood nutrition. Founded in 2019 and headquartered in Tel Aviv, Israel, Else Nutrition began commercial sales in 2021 with initial distribution in Canada and Israel. Its manufacturing takes place in European Union-certified facilities, and products are sold through e-commerce channels as well as selected retail partners. Beyond Canada and Israel, Else Nutrition has entered into distribution partnerships in parts of Europe and is working toward regulatory approvals to support an expansion into the U.S. market. Led by CEO Hadar Barshewitz-Attias and a management team with backgrounds in nutrition science and consumer packaged goods, Else Nutrition places a strong emphasis on research and development. The company is investing in clinical studies and regulatory compliance to support the safety and efficacy of its existing products, while also exploring the development of additional age-stage formulas and new delivery formats within the plant-based pediatric nutrition category.AI Generated. May Contain Errors. Read More Receive BABYF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Else Nutrn and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BABYF Stock News HeadlinesElse Nutrition Holdings Inc.: Else Nutrition Reports First Quarter 2026 Results Highlighting Significant Improvement in Gross Margin and Reduced Net LossMay 16 at 8:42 AM | finanznachrichten.deElse Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027April 15, 2026 | prnewswire.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.May 17 at 1:00 AM | Weiss Ratings (Ad)Else Nutrition Holdings Inc.: Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein StandardsMarch 10, 2026 | finanznachrichten.deElse Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein StandardsMarch 10, 2026 | prnewswire.comElse Nutrition Surpasses One Million Cans Sold Since LaunchJanuary 29, 2026 | prnewswire.comElse Nutrition Announces Results from Annual General Meeting of ShareholdersJanuary 12, 2026 | prnewswire.comElse Nutrition Plans Canadian Market Relaunch in 2026January 7, 2026 | prnewswire.comSee More Headlines BABYF Stock Analysis - Frequently Asked Questions How have BABYF shares performed this year? Else Nutrn's stock was trading at $0.0777 at the beginning of the year. Since then, BABYF stock has decreased by 58.3% and is now trading at $0.0324. How were Else Nutrn's earnings last quarter? Else Nutrn Hldg (OTCMKTS:BABYF) announced its quarterly earnings results on Friday, May, 15th. The company reported ($0.03) earnings per share for the quarter. How do I buy shares of Else Nutrn? Shares of BABYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/15/2026Today5/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED PRODUCTS Sub-IndustryN/A Current SymbolOTCMKTS:BABYF CIK1807936 Webwww.elsenutrition.com Phone888-879-3573FaxN/AEmployees32Year Founded2018Profitability EPS (Trailing Twelve Months)($0.63) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.37 million Net Margins-148.32% Pretax Margin-148.41% Return on EquityN/A Return on Assets-210.96% Debt Debt-to-Equity RatioN/A Current Ratio0.69 Quick Ratio0.20 Sales & Book Value Annual Sales$4.32 million Price / Sales0.36 Cash FlowN/A Price / Cash FlowN/A Book Value$0.06 per share Price / Book0.54Miscellaneous Outstanding Shares47,941,000Free FloatN/AMarket Cap$1.55 million OptionableNot Optionable Beta0.78 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (OTCMKTS:BABYF) was last updated on 5/17/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the bigg...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Else Nutrn Hldg Please log in to your account or sign up in order to add this asset to your watchlist. Share Else Nutrn With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
